Kevin Koch

Progress towards therapeutic small molecule MEK inhibitors for use in cancer therapy.

J. Lyssikatos, K. Koch, J. Winkler, 2005, Current topics in medicinal chemistry.

Biological Characterization of ARRY-142886 (AZD6244), a Potent, Highly Selective Mitogen-Activated Protein Kinase Kinase 1/2 Inhibitor

Vivienne Marsh, S. Gross, B. Brandhuber, 2007, Clinical Cancer Research.